Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Intestinal Neuroendocrine Tumor × Endocrine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 148 Carcinoma, Neuroendocrine 51 Thyroid Cancer, Papillary 46 Pheochromocytoma 43 Thyroid Neoplasms 42 Paraganglioma 33 Multiple Endocrine Neoplasia Type 1 33 Pituitary Neoplasms 32 Neoplasms 30 Adrenocortical Carcinoma 28 Gastro-enteropancreatic neuroendocrine tumor 26 Thyroid Carcinoma, Anaplastic 21 Small Cell Lung Carcinoma 20 Sarcoma 20 Carcinoid Tumor 20 Lung Neoplasms 19 Colorectal Neoplasms 19 Carcinoma, Non-Small-Cell Lung 18 Breast Neoplasms 18 Stomach Neoplasms 17 Pancreatic Neoplasms 17 Carcinoma, Hepatocellular 17 Ovarian Neoplasms 16 Neoplasm Metastasis 16 Melanoma 16 Adrenal Gland Neoplasms 16 Adenoma, Islet Cell 16 Prostatic Neoplasms 14 Uterine Cervical Neoplasms 13 Neuroblastoma 13

Interventions

Serum Albumin 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡